For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

PGP69

1390

Dr.Ranjitha C S
Membership No Author Name Email Mobile
4679MW Dr.Bhoomika Srinivas bsgowda2000@gmail.com 9902030818
Cornea, Ocular Surface and External Eye Diseases

RIPASUDIL-INDUCED HONEYCOMB KERATOPATHY IN PSEUDOPHAKIC BULLOUS KERATOPATHY : A THREE-CASE SERIES

PURPOSE 
To describe the clinical features and outcomes of Ripasudil-induced Honeycomb Keratopathy in eyes with pseudophakic bullous keratopathy and highlight this reversible adverse effect. 

METHODS 
This retrospective case series included three patients with pseudophakic bullous keratopathy who developed decreased vision after Topical Ripasudil 0.4%, prescribed elsewhere for endothelial support. Slit-lamp examination confirmed honeycomb keratopathy. Ripasudil was discontinued, and patients were followed to document resolution. 

RESULTS 
All three patients showed complete resolution of the honeycomb keratopathy changes within one week of discontinuing Ripasudil, with improvement in visual symptoms, supporting the diagnosis of Ripasudil-induced honeycomb keratopathy.

CONCLUSIONS
Ripasudil may cause reversible honeycomb keratopathy in eyes with corneal endothelial decompensation. Early recognition and prompt discontinuation facilitate recovery and prevent unnecessary interventions.

Membership No Author Name Email Mobile
3180N Dr.Gundareddy Sai Preethi Reddy reddy.drpreethi@gmail.com 9972852728